デフォルト表紙
市場調査レポート
商品コード
1019725

医薬品開発業務受託機関 (CRO) の市場動向・市場シェア・市場規模の予測 (2021-2028年):ステージ (創薬・前臨床・臨床)・サービス (臨床モニタリング・データ管理)・地域別

Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Service (Clinical Monitoring, Data Management), By Region, And Segment Forecasts, 2021 - 2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 120 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.26円
医薬品開発業務受託機関 (CRO) の市場動向・市場シェア・市場規模の予測 (2021-2028年):ステージ (創薬・前臨床・臨床)・サービス (臨床モニタリング・データ管理)・地域別
出版日: 2021年06月21日
発行: Grand View Research, Inc.
ページ情報: 英文 120 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医薬品開発業務受託機関 (CRO) の市場規模は予測期間中6.6%のCAGRで推移し、2028年には660億米ドルの規模に成長すると予測されています。

医薬品開発コストの増加、臨床試験コストの上昇、患者の募集に関する課題により、バイオ医薬品企業は中東欧、アジア太平洋、中南米、中近東などの地域に目を向けるようになりました。また、厳しいスケジュールの圧力から研究活動をCROに委託する需要が高まっています。

当レポートでは、世界の医薬品開発業務受託機関 (CRO) の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、ステージ・サービス・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 市場可変因子・動向・展望

  • 市場の分類・範囲
  • 市場成長要因
  • 市場抑制要因
  • 普及・成長の見通しマッピング
  • ポーターのファイブフォース分析
  • PESTEL分析

第4章 COVID-19:影響分析

第5章 市場予測・動向分析:ステージ別

  • 創薬
  • 前臨床
  • 臨床

第6章 市場予測・動向分析:サービス別

  • プロジェクト管理/臨床供給管理
  • データ管理
  • 法規制・薬事
  • メディカルライティング
  • 臨床モニタリング
  • 品質管理/保証
  • バイオ統計
  • 治験費用支払い
  • ラボ
  • 患者・サイト募集
  • 技術サービス
  • その他

第7章 市場予測・動向分析:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 主要CROのリスト
  • 企業プロファイル
    • IQVIA HOLDINGS INC.
    • Covance Inc.
    • Pharmaceutical Product Development, LLC(PPD)
    • PAREXEL INTERNATIONAL CORPORATION
    • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
    • ICON, plc
    • Medidata Solutions, Inc.
    • Syneos Health
    • Pharmaron
    • GVK Biosciences Private Limited
    • Wuxi AppTec
    • MEDPACE HOLDINGS, INC.
    • PRA Health Sciences
    • CTI Clinical Trial & Consulting
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Healthcare Contract Research Outsourcing Market, by Region, 2016 - 2028 (USD Million)
  • Table 4 Global Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 5 Global Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 6 Global Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 7 Global Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 8 North America Healthcare Contract Research Outsourcing Market, by Country, 2016 - 2028 (USD Million)
  • Table 9 North America Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 10 North America Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 11 North America Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 12 North America Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 13 U.S. Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 14 U.S. Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 15 U.S. Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 16 U.S. Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 17 Canada Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 18 Canada Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 19 Canada Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 20 Canada Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 21 Europe Healthcare Contract Research Outsourcing Market, by Country, 2016 - 2028 (USD Million)
  • Table 22 Europe Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 23 Europe Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 24 Europe Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 25 Europe Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 26 U.K. Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 27 U.K. Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 28 U.K. Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 29 U.K. Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 30 Germany Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 31 Germany Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 32 Germany Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 33 Germany Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 34 France Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 35 France Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 36 France Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 37 France Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 38 Italy Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 39 Italy Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 40 Italy Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 41 Italy Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 42 Spain Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 43 Spain Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 44 Spain Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 45 Spain Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 46 Switzerland Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 47 Switzerland Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 48 Switzerland Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 49 Switzerland Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 50 Belgium Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 51 Belgium Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 52 Belgium Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 53 Belgium Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 54 Netherlands Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 55 Netherlands Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 56 Netherlands Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 57 Netherlands Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 58 Austria Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 59 Austria Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 60 Austria Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 61 Austria Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 62 Asia Pacific Healthcare Contract Research Outsourcing Market, by Country, 2016 - 2028 (USD Million)
  • Table 63 Asia Pacific Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 64 Asia Pacific Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 65 Asia Pacific Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 66 Asia Pacific Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 67 India Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 68 India Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 69 India Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 70 India Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 71 China Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 72 China Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 73 China Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 74 China Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 75 Taiwan Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 76 Taiwan Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 77 Taiwan Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 78 Taiwan Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 79 Japan Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 80 Japan Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 81 Japan Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 82 Japan Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 83 Korea Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 84 Korea Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 85 Korea Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 86 Korea Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 87 Australia Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 88 Australia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 89 Australia Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 90 Australia Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 91 Indonesia Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 92 Indonesia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 93 Indonesia Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 94 Indonesia Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 95 Malaysia Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 96 Malaysia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 97 Malaysia Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 98 Malaysia Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 99 Singapore Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 100 Singapore Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 101 Singapore Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 102 Singapore Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 103 Thailand Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 104 Thailand Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 105 Thailand Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 106 Thailand Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 107 Latin America Healthcare Contract Research Outsourcing Market, by Country, 2016 - 2028 (USD Million)
  • Table 108 Latin America Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 109 Latin America Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 110 Latin America Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 111 Latin America Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 112 Brazil Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 113 Brazil Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 114 Brazil Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 115 Brazil Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 116 Mexico Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 117 Mexico Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 118 Mexico Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 119 Mexico Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 120 Argentina Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 121 Argentina Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 122 Argentina Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 123 Argentina Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 124 Colombia Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 125 Colombia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 126 Colombia Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 127 Colombia Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 128 Chile Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 129 Chile Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 130 Chile Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 131 Chile Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 132 MEA Healthcare Contract Research Outsourcing Market, by Country, 2016 - 2028 (USD Million)
  • Table 133 MEA Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 134 MEA Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 135 MEA Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 136 MEA Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 137 South Africa Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 138 South Africa Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 139 South Africa Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 140 South Africa Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 141 Saudi Arabia Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 142 Saudi Arabia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 143 Saudi Arabia Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 144 Saudi Arabia Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 145 UAE Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 146 UAE Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 147 UAE Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 148 UAE Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 149 Iran Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 150 Iran Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 151 Iran Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 152 Iran Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 153 Israel Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 154 Israel Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 155 Israel Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 156 Israel Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)
  • Table 157 Egypt Healthcare Contract Research Outsourcing Market, by Type, 2016 - 2028 (USD Million)
  • Table 158 Egypt Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2016 - 2028 (USD Million)
  • Table 159 Egypt Healthcare Contract Research Outsourcing Market, by Trials, 2016 - 2028 (USD Million)
  • Table 160 Egypt Healthcare Contract Research Outsourcing Market, by Service, 2016 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Healthcare CRO market snapshot (2020)
  • Fig. 9 Market trends and outlook
  • Fig. 10 Healthcare CRO market segmentation
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Benefits of using robotic labs
  • Fig. 13 Pharmaceutical R&D spending, 2015-2024 (USD billion)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 Penetration & growth prospect mapping
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 Healthcare CRO market stage outlook: Segment dashboard
  • Fig. 19 Healthcare CRO market: Stage movement analysis
  • Fig. 20 Drug discovery market, 2016 - 2028 (USD Million)
  • Fig. 21 Target validation market, 2016 - 2028 (USD Million)
  • Fig. 22 Lead identification market, 2016 - 2028 (USD Million)
  • Fig. 23 Lead optimization market, 2016 - 2028 (USD Million)
  • Fig. 24 Preclinical market, 2016 - 2028 (USD Million)
  • Fig. 25 Clinical market, 2016 - 2028 (USD Million)
  • Fig. 26 Phase I trial services market, 2016 - 2028 (USD Million)
  • Fig. 27 Phase II trial services market, 2016 - 2028 (USD Million)
  • Fig. 28 Phase III trial services market, 2016 - 2028 (USD Million)
  • Fig. 29 Phase IV trial services market, 2016 - 2028 (USD Million)
  • Fig. 30 Healthcare CRO market service outlook: Segment dashboard
  • Fig. 31 Healthcare CRO market: Service movement analysis
  • Fig. 32 Parameters for measuring success of provider solution
  • Fig. 33 Project management/clinical supply management market, 2016 - 2028 (USD Million)
  • Fig. 34 Clinical data management flow
  • Fig. 35 Data management market, 2016 - 2028 (USD Million)
  • Fig. 36 Regulatory/medical affairs market, 2016 - 2028 (USD Million)
  • Fig. 37 Medical writing market, 2016 - 2028 (USD Million)
  • Fig. 38 Clinical monitoring market, 2016 - 2028 (USD Million)
  • Fig. 39 Quality management/ assurance market, 2016 - 2028 (USD Million)
  • Fig. 40 Bio-statistics market, 2016 - 2028 (USD Million)
  • Fig. 41 Investigator payments market, 2016 - 2028 (USD Million)
  • Fig. 42 Laboratory market, 2016 - 2028 (USD Million)
  • Fig. 43 Strategic initiatives with positive impact on patient recruitment
  • Fig. 44 Patient and site recruitment market, 2016 - 2028 (USD Million)
  • Fig. 45 Technology services market, 2016 - 2028 (USD Million)
  • Fig. 46 Other services market, 2016 - 2028 (USD Million)
  • Fig. 47 Regional market: Key takeaways
  • Fig. 48 Regional outlook, 2020 & 2028
  • Fig. 49 North America market, 2016 - 2028 (USD Million)
  • Fig. 50 U.S. market, 2016 - 2028 (USD Million)
  • Fig. 51 Canada market, 2016 - 2028 (USD Million)
  • Fig. 52 Europe market, 2016 - 2028 (USD Million)
  • Fig. 53 U.K. market, 2016 - 2028 (USD Million)
  • Fig. 54 Germany market, 2016 - 2028 (USD Million)
  • Fig. 55 France market, 2016 - 2028 (USD Million)
  • Fig. 56 Italy market, 2016 - 2028 (USD Million)
  • Fig. 57 Spain market, 2016 - 2028 (USD Million)
  • Fig. 58 Switzerland market, 2016 - 2028 (USD Million)
  • Fig. 59 Belgium market, 2016 - 2028 (USD Million)
  • Fig. 60 Netherlands market, 2016 - 2028 (USD Million)
  • Fig. 61 Austria market, 2016 - 2028 (USD Million)
  • Fig. 62 Asia Pacific market, 2016 - 2028 (USD Million)
  • Fig. 63 India market, 2016 - 2028 (USD Million)
  • Fig. 64 China market, 2016 - 2028 (USD Million)
  • Fig. 65 Taiwan market, 2016 - 2028 (USD Million)
  • Fig. 66 Japan market, 2016 - 2028 (USD Million)
  • Fig. 67 Korea market, 2016 - 2028 (USD Million)
  • Fig. 68 Australia market, 2016 - 2028 (USD Million)
  • Fig. 69 Indonesia market, 2016 - 2028 (USD Million)
  • Fig. 70 Malaysia market, 2016 - 2028 (USD Million)
  • Fig. 71 Singapore market, 2016 - 2028 (USD Million)
  • Fig. 72 Thailand market, 2016 - 2028 (USD Million)
  • Fig. 73 Latin America market, 2016 - 2028 (USD Million)
  • Fig. 74 Brazil market, 2016 - 2028 (USD Million)
  • Fig. 75 Mexico market, 2016 - 2028 (USD Million)
  • Fig. 76 Argentina market, 2016 - 2028 (USD Million)
  • Fig. 77 Colombia market, 2016 - 2028 (USD Million)
  • Fig. 78 Chile market, 2016 - 2028 (USD Million)
  • Fig. 79 MEA market, 2016 - 2028 (USD Million)
  • Fig. 80 South Africa market, 2016 - 2028 (USD Million)
  • Fig. 81 Saudi Arabia market, 2016 - 2028 (USD Million)
  • Fig. 82 UAE market, 2016 - 2028 (USD Million)
  • Fig. 83 Iran market, 2016 - 2028 (USD Million)
  • Fig. 84 Israel market, 2016 - 2028 (USD Million)
  • Fig. 85 Egypt market, 2016 - 2028 (USD Million)
目次
Product Code: 978-1-68038-688-2

Healthcare Contract Research Organization Market Growth & Trends

The global healthcare contract research organization market size is expected to reach USD 66.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.6% from 2021 to 2028. The increasing cost of drug development is expected to drive market demand over the forecast period. Also, rising clinical trials cost and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and Middle East for cost savings and quick patient recruitment.

In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing research activities to Contract Research Organizations (CROs). Some government organizations are also outsourcing their clinical trial activities so that they can carry out clinical trials with the required infrastructure, expertise, and minimize their cost and timelines.

However, the COVID-19 pandemic has significantly impacted the CRO market. The worldwide focus on finding a vaccine against coronavirus has had a significant impact on the development of other vaccines and drugs. At the peak of the pandemic, vaccines and treatments for COVID-19 accounted for 30% of all the trials in the U.S. This resulted in other trials being put on hold.

The CRO market is recovering slowly through a hybrid approach. They are playing a significant role in helping sponsors and sites to start clinical trials. Market players have already built powerful tools to support virtual clinical trials. They are ready to rapidly assist sponsors to shift to this new environment and leverage the available tools.

Healthcare Contract Research Organization Market Report Highlights

The clinical trial services segment dominated the market in 2020 and accounted for the largest revenue share of 76.7% owing to the fact that it comprises four elaborate phases, including human subjects

The clinical monitoring segment was the largest in terms of revenue share in 2020

North America held a significant revenue share of 25.7% in 2020 due to the presence of several global players, who invest a major part of their revenue in research activities

In Asia Pacific, the market is anticipated to witness a lucrative growth rate of 8.1% over the forecast period due to the reduced cost it offers in comparison to the U.S and other developed economies

China, Japan, and India are projected to witness tremendous growth in the market owing to high disease prevalence

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Type
    • 1.1.2 Service
    • 1.1.3 Regional scope
    • 1.1.4 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR'S internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 DATA ANALYSIS MODELS
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 COMMODITY FLOW ANALYSIS (MODEL 1)
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1:
    • 1.10.2 Objective - 2:
    • 1.10.3 Objective - 3:
    • 1.10.4 Objective - 4:

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Healthcare CRO Market: Variables, Trends, & Scope

  • 3.1 Market Segmentation and Scope
  • 3.2 Market Driver Analysis
    • 3.2.1 Increasing adoption of advanced technologies
    • 3.2.2 Increasing mergers and collaborations
    • 3.2.3 Increasing outsourcing of R&D activities
    • 3.2.4 Patent cliff
    • 3.2.5 Favorable environment for clinical trials in developing countries
  • 3.3 Market Restraint Analysis
    • 3.3.1 Quality issues of CRO services
    • 3.3.2 Intellectual property rights issues
  • 3.4 Penetration & Growth Prospect Mapping
  • 3.5 Porter's Five Forces Analysis
  • 3.6 PESTEL Analysis

Chapter 4 COVID-19 Impact Analysis

  • 4.1 COVID-19 Impact on Clinical Trial Services Market
  • 4.2 COVID-19 Impact on Regulatory Services Market
  • 4.3 COVID-19 Impact on Biopharmaceutical CRO Market
  • 4.4 COVID-19 Impact on Key Market Players
    • 4.4.1 IQVIA
    • 4.4.2 SYNEOS HEALTH
    • 4.4.3 ICON PLC
    • 4.4.4 LAB CORP
    • 4.4.5 PPD
    • 4.4.6 CHARLES RIVER Laboratories

Chapter 5 Healthcare CRO Market: Stage Segment Analysis

  • 5.1 Healthcare CRO: Market Share Analysis, 2020 & 2028
  • 5.2 Drug Discovery
    • 5.2.1 Drug Discovery market, 2016 - 2028 (USD Million)
    • 5.2.2 Target validation
      • 5.2.2.1 Target validation market, 2016 - 2028 (USD Million)
    • 5.2.3 Lead identification
      • 5.2.3.1 Lead identification market, 2016 - 2028 (USD Million)
    • 5.2.4 Lead optimization
      • 5.2.4.1 Lead optimization market, 2016 - 2028 (USD Million)
  • 5.3 Pre-clinical
    • 5.3.1 Pre-clinical market, 2016 - 2028 (USD Million)
  • 5.4 Clinical
    • 5.4.1 Clinical market, 2016 - 2028 (USD Million)
    • 5.4.2 Phase I Trial Services
      • 5.4.2.1 Phase I trial services market, 2016 - 2028 (USD Million)
    • 5.4.3 Phase II Trial Services
      • 5.4.3.1 Phase II trial services market, 2016 - 2028 (USD Million)
    • 5.4.4 Phase III Trial Services
      • 5.4.4.1 Phase III trial services market, 2016 - 2028 (USD Million)
    • 5.4.5 Phase IV Trial Services
      • 5.4.5.1 Phase IV trial services market, 2016 - 2028 (USD Million)

Chapter 6 Healthcare CRO Market: Service Segment Analysis

  • 6.1 Healthcare CRO: Market Share Analysis, 2020 & 2028
  • 6.2 Project Management/Clinical Supply Management
    • 6.2.1 Project Management/Clinical Supply Management market, 2016 - 2028 (USD Million)
  • 6.3 Data Management
    • 6.3.1 Data Management market, 2016 - 2028 (USD Million)
  • 6.4 Regulatory/Medical Affairs
    • 6.4.1 Regulatory/Medical Affairs market, 2016 - 2028 (USD Million)
  • 6.5 Medical Writing
    • 6.5.1 Medical Writing market, 2016 - 2028 (USD Million)
  • 6.6 Clinical Monitoring
    • 6.6.1 Clinical Monitoring market, 2016 - 2028 (USD Million)
  • 6.7 Quality Management/ Assurance
    • 6.7.1 Quality Management/ Assurance market, 2016 - 2028 (USD Million)
  • 6.8 Bio-statistics
    • 6.8.1 Bio-statistics market, 2016 - 2028 (USD Million)
  • 6.9 Investigator Payments
    • 6.9.1 Investigator Payments market, 2016 - 2028 (USD Million)
  • 6.10 Laboratory
    • 6.10.1 Laboratory market, 2016 - 2028 (USD Million)
  • 6.11 Patient and Site Recruitment
    • 6.11.1 Patient and site Recruitment market, 2016 - 2028 (USD Million)
  • 6.12 Technology Services
    • 6.12.1 Technology services market, 2016 - 2028 (USD Million)
  • 6.13 Other Services
    • 6.13.1 Other services market, 2016 - 2028 (USD Million)

Chapter 7 Healthcare CRO Market: Service Segment Analysis

  • 7.1 Healthcare CRO: Market Share Analysis, 2020 & 2028
  • 7.2 North America
    • 7.2.1 North America Healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada healthcare CRO market, 2016 - 2028 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe Healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.3.2 U.K.
      • 7.3.2.1 U.K. healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Italy healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Spain healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.3.7 Switzerland
      • 7.3.7.1 Switzerland healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.3.8 Belgium
      • 7.3.8.1 Belgium healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.3.9 Netherlands
      • 7.3.9.1 Netherlands healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.3.10 Austria
      • 7.3.10.1 Austria healthcare CRO market, 2016 - 2028 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.4.2 India
      • 7.4.2.1 India healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.4.4 Taiwan
      • 7.4.4.1 Taiwan healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.4.5 Japan
      • 7.4.5.1 Japan healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.4.6 Korea
      • 7.4.6.1 Korea healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.4.7 Australia
      • 7.4.7.1 Australia healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.4.8 Indonesia
      • 7.4.8.1 Indonesia healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.4.9 Malaysia
      • 7.4.9.1 Malaysia healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.4.10 Singapore
      • 7.4.10.1 Singapore healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.4.11 Thailand
      • 7.4.11.1 Thailand healthcare CRO market, 2016 - 2028 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.5.5 Colombia
      • 7.5.5.1 Colombia healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.5.6 Chile
      • 7.5.6.1 Chile healthcare CRO market, 2016 - 2028 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 UAE healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.6.5 Iran
      • 7.6.5.1 Iran healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.6.6 Israel
      • 7.6.6.1 Israel healthcare CRO market, 2016 - 2028 (USD Million)
    • 7.6.7 Egypt
      • 7.6.7.1 Egypt healthcare CRO market, 2016 - 2028 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 List of the top CROs global as well as MENA region
  • 8.2 Company Profiles
    • 8.2.1 IQVIA HOLDINGS INC.
      • 8.2.1.1 Company overview
      • 8.2.1.2 Financial performance
      • 8.2.1.3 Service benchmarking
      • 8.2.1.4 Strategic initiatives
    • 8.2.2 Covance Inc.
      • 8.2.2.1 Company overview
      • 8.2.2.2 Financial performance
      • 8.2.2.3 Service benchmarking
      • 8.2.2.4 Strategic initiatives
    • 8.2.3 Pharmaceutical Product Development, LLC (PPD)
      • 8.2.3.1 Company overview
      • 8.2.3.2 Financial performance
      • 8.2.3.3 Service benchmarking
      • 8.2.3.4 Strategic initiatives
    • 8.2.4 PAREXEL INTERNATIONAL CORPORATION
      • 8.2.4.1 Company overview
      • 8.2.4.2 Financial Performance
      • 8.2.4.3 Service benchmarking
      • 8.2.4.4 Strategic initiatives
    • 8.2.5 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
      • 8.2.5.1 Company overview
      • 8.2.5.2 Financial performance
      • 8.2.5.3 Service benchmarking
      • 8.2.5.4 Strategic initiatives
    • 8.2.6 ICON, plc
      • 8.2.6.1 Company overview
      • 8.2.6.2 Financial performance
      • 8.2.6.3 Service benchmarking
      • 8.2.6.4 Strategic initiatives
    • 8.2.7 Medidata Solutions, Inc.
      • 8.2.7.1 Company overview
      • 8.2.7.2 Financial performance
      • 8.2.7.3 Service benchmarking
      • 8.2.7.4 Strategic initiatives
    • 8.2.8 Syneos Health
      • 8.2.8.1 Company overview
      • 8.2.8.2 Financial performance
      • 8.2.8.3 Service benchmarking
      • 8.2.8.4 Strategic initiatives
    • 8.2.9 Pharmaron
      • 8.2.9.1 Company overview
      • 8.2.9.2 Service benchmarking
      • 8.2.9.3 Strategic initiatives
    • 8.2.10 GVK Biosciences Private Limited
      • 8.2.10.1 Company overview
      • 8.2.10.2 Service benchmarking
    • 8.2.11 Wuxi AppTec
      • 8.2.11.1 Company overview
      • 8.2.11.2 Financial performance
      • 8.2.11.3 Service benchmarking
      • 8.2.11.4 Strategic initiatives
    • 8.2.12 MEDPACE HOLDINGS, INC.
      • 8.2.12.1 Company overview
      • 8.2.12.2 Financial performance
      • 8.2.12.3 Service benchmarking
    • 8.2.13 PRA Health Sciences
      • 8.2.13.1 Company overview
      • 8.2.13.2 Financial performance
      • 8.2.13.3 Service benchmarking
      • 8.2.13.4 Strategic initiatives
    • 8.2.14 CTI Clinical Trial & Consulting
      • 8.2.14.1 Company overview
      • 8.2.14.2 Service benchmarking
      • 8.2.14.3 Strategic initiatives